US stock · US markets · public data

EW

Edwards Lifesciences Corp · Healthcare

Reference price$86.45Updated according to the public source
P/E51.46
P/B4.69
ROE9.18%
DY 12M0.00%
Net margin—
Net debt/equity—
Market capUS$ 49.8 B
Volume (shares)4,001,294
SectorHealthcare
Overview

About EW

Demonstrações públicas consolidadas + SEC Company Facts

Edwards Lifesciences Corp (EW) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$5,010,000,000.00$5,439,500,000.00$6,067,600,000.00—
Gross Profit$4,031,600,000.00$4,322,000,000.00$4,733,400,000.00—
Operating Income$1,308,900,000.00$1,378,700,000.00$1,264,200,000.00—
Net Income$1,399,400,000.00$4,169,700,000.00$1,069,400,000.00—
EPS Diluted$2.30 / share$6.97 / share$1.83 / share—

Balance sheet

Account2023202420252026
Total Assets$9,363,200,000.00$13,055,300,000.00$13,697,200,000.00—
Total Liabilities$2,643,800,000.00$2,992,400,000.00$3,359,600,000.00—
Total Equity$6,650,000,000.00$9,998,400,000.00$10,337,600,000.00—
Long-term Debt$597,000,000.00$597,700,000.00$598,300,000.00—
Current Debt————
Shares Outstanding608,313,396 shares601,300,000 shares587,900,000 shares580,800,000 shares
Cash & Investments$2,216,700,000.00$4,283,800,000.00$4,504,900,000.00—
Dívida Líquida————

Cash flow

Account2023202420252026
Operating Cash Flow$895,800,000.00$542,300,000.00$1,595,200,000.00—
Capital Expenditures$253,000,000.00$252,400,000.00$260,200,000.00—
Free Cash Flow$642,800,000.00$289,900,000.00$1,335,000,000.00—
FAQ

Frequently asked questions

What is the price of EW?

The reference price available for EW is $86.45.

What is the P/E of EW?

The P/E ratio of EW is 51.46. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of EW?

The P/B of EW is 4.69. This compares price with reported book value per share.

What is the ROE of EW?

The ROE (Return on Equity) of EW is 9.18%. This relates the reported net result to shareholders' equity.

What is the dividend yield of EW?

The dividend yield of EW is 0.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of EW?

The market capitalization of EW is US$ 49.8 B.

What sector is EW in?

EW operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.